Targeting Triple-Negative Breast Cancer Metabolism Via Engineered Virus-Like Vesicle-Mediated Drug Delivery

Authors

Institutions

Publication Details

Journal
eCommons (Cornell University)
Published
2026-04-02
DOI
https://doi.org/10.7298/6wyh-vj21
Primary Topic
interferon and immune responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Targeting Triple-Negative Breast Cancer Metabolism Via Engineered Virus-Like Vesicle-Mediated Drug Delivery

K. Chul Chong
eCommons (Cornell University)
interferon and immune responses
article

Targeting Triple-Negative Breast Cancer Metabolism Via Engineered Virus-Like Vesicle-Mediated Drug Delivery

K. Chul Chong
article en

Abstract

No abstract available for this paper.
eCommons (Cornell University)
Cornell University (US)
Good health and well-being
Openalex Percentile: Top 25%
interferon and immune responses
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.